agent

SINOVAC Board of Directors Prevails Against Advantech/Primes New York Lawsuit

New York Court Denies Advantech/Prime’s Petition for Emergency Injunctive Relief Clears Legal Hurdle for Dividend Paying Agent to Payout the…

2 weeks ago

C.H. Robinson Launches an AI Agent to Help Shippers Adapt to the New National System for Classifying LTL Freight

The global logistics provider’s latest innovation with artificial intelligence also marks a new frontier: building AI agents that assist other…

2 weeks ago

Agora and WIZ.AI Partner to Deliver Enterprise-Ready AI Agent Solutions

Advanced AI agents from Agora and WIZ.AI can power call centers with multilingual support and contextual understanding SANTA CLARA, Calif., June…

2 weeks ago

Draganfly Announces Closing of US$13.75 Million Public Offering

Saskatoon, SK., June 12, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”),…

3 weeks ago

Databricks Launches Agent Bricks: A New Approach to Building AI Agents

Agent Bricks automatically optimizes AI agents on customers' unique data to deliver cost-efficient, trustworthy agents SAN FRANCISCO, June 11, 2025…

3 weeks ago

Databricks Launches Lakebase: a New Class of Operational Database for AI Apps and Agents

Fully-managed, Postgres database built to unify analytics and operations for intelligent apps SAN FRANCISCO, June 11, 2025 /PRNewswire/ -- Data…

3 weeks ago

XerpaAI Launches the Worlds First AI Growth Agent (AGA), Ushering in a New Era Beyond CMOs and CGOs

SINGAPORE, June 10, 2025 (GLOBE NEWSWIRE) -- Today marks a historic turning point in the evolution of growth leadership: XerpaAI,…

3 weeks ago

Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

TORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical…

3 weeks ago

Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response

Treatment with casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor, showed a confirmed overall response rate (ORR) of…

1 month ago